In alcohol use disorder and comorbid obesity, weekly semaglutide reduced heavy drinking days at 26 wk

Annals of Internal Medicine · Published 2026-08-03 · DOI 10.7326/annals-26-02636-jc

Authors (2)

Mat Rose, ACP Journal Club Editorial Team at McMaster University

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Rose, M., University, A. (2026). In alcohol use disorder and comorbid obesity, weekly semaglutide reduced heavy drinking days at 26 wk. Annals of Internal Medicine. https://doi.org/10.7326/annals-26-02636-jc

Related articles